This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ikoma, JP (2019 - 2020)
- Osaka, JP (2020 - 2021)
Company Filing History:
Years Active: 2019-2021
Title: Innovations by Yoshihiro Oshita in Ophthalmic Solutions
Introduction
Yoshihiro Oshita is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of ophthalmology, particularly in developing solutions for dry eye conditions. With a total of 4 patents to his name, his work has had a meaningful impact on patient care.
Latest Patents
Oshita's latest patents include a therapeutic agent specifically designed for dry eye patients who wear soft contact lenses. This ophthalmic solution comprises diquafosol tetrasodium salt and is free from benzalkonium chloride, effectively treating the onset and exacerbation of dry eye symptoms. Another significant patent is an aqueous ophthalmic solution that includes diquafosol or a salt thereof at a concentration of 0.1% to 10% (w/v) along with chlorhexidine at a concentration of 0.0001% to 0.1% (w/v). These innovations showcase his commitment to improving eye health.
Career Highlights
Oshita is currently associated with Santen Pharmaceutical Co., Ltd., a company renowned for its focus on ophthalmic products. His work at Santen has allowed him to collaborate with other experts in the field, further enhancing the quality of his inventions.
Collaborations
Some of his notable coworkers include Asuka Kamimura and Hitoshi Nakazawa. Their collaborative efforts have contributed to the advancement of ophthalmic solutions and the overall mission of Santen Pharmaceutical.
Conclusion
Yoshihiro Oshita's contributions to ophthalmology through his innovative patents reflect his dedication to improving the quality of life for individuals suffering from dry eye conditions. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
